AI driven differentiation Pregmune leverages artificial intelligence and data science to identify overlooked infertility causes, presenting a unique value proposition for clinics and fertility centers seeking advanced diagnostic tools and personalized treatment plans.

IRMA as core offering IRMA provides a comprehensive, AI-assisted assessment of blood, genetic markers, and autoimmune/inflammatory indicators, enabling partners to offer a structured, data-backed fertility evaluation to their patients.

Partnerable testing Some tests involve both partners when feasible, creating collaboration opportunities with donor programs and partner clinics to expand testing scope and shared outcomes.

Growth through accessibility With a lean revenue base and recent product launch, there is upside in white-label or co-branded deployments, plus expansion into clinics seeking scalable fertility analytics.

Market positioning Compared to larger genetics players, Pregmune occupies a niche focused on reproductive immunology and implantation risk, offering an entry point for mid-market fertility networks seeking innovative differentiation.